Clinical trial

Immune-Marker Platform for Patients With Advanced Lung Cancer

NCT07150598

StatusNOT_YET_RECRUITING

Study typeOBSERVATIONAL

Start date2025-09-01

PhaseN/A

Study timeline

Study start (estimated)2025-09-01Date precision: day

Registry last updated2025-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

NSCLC (Advanced Non-small Cell Lung Cancer)unresolved

NSCLC Stage IIIB~IVunresolved

NSCLC Non-small Cell Lung Cancerunresolved

Interventions

Sponsors & collaborators

Technische Universität Dresdenlead sponsor

Deutsche Krebshilfe e.V., Bonn (Germany)collaborator

Universitätsklinikum Kölncollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07150598 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.